Grading of dysplasia.

[1]  C. Williams,et al.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.

[2]  C. Bernstein,et al.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? , 1994, The Lancet.

[3]  R. Haggitt,et al.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. , 1993, Gastroenterology.

[4]  M. Kimmey,et al.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.

[5]  A. Zinsmeister,et al.  Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance , 1992, Diseases of the colon and rectum.

[6]  R. Löfberg,et al.  DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. , 1992, Gastroenterology.

[7]  R. Löfberg,et al.  Highly malignant carcinoma in chronic ulcerative colitis without preceding dysplasia or DNA aneuploidy , 1992, Diseases of the colon and rectum.

[8]  J. Jass,et al.  Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. , 1989, Human pathology.

[9]  A. Price,et al.  Observer variation in the assessment of dysplasia in ulcerative colitis , 1988, Histopathology.

[10]  H. W. Jones,et al.  Surveillance in ulcerative colitis: burdens and benefit. , 1988, Gut.

[11]  L. Ghandur-Mnaymneh,et al.  Dysplasia of Nonmetaplastic Gastric Mucosa: A Proposal for its Classification and its Possible Relationship to Diffuse‐Type Gastric Carcinoma , 1988, The American journal of surgical pathology.

[12]  D. Ransohoff,et al.  Ulcerative colitis and colonic cancer , 1985, Diseases of the colon and rectum.

[13]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.